Clinical trial
A Prospective, Multi-center Clinical Study of Palliative Transurethral Plasma Kinetic Resection of Prostate (TUPKRP) Combined With Endocrine Therapy for Advanced Prostate Cancer Complicated With Severe Lower Urinary Tract Symptoms
NCT03701659 is registered in ClinicalTrials.gov with The Third Xiangya Hospital of Central South University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center Clinical Study of Palliative Transurethral Plasma Kinetic Resection of Prostate (TUPKRP) Combined With Endocrine Therapy for Advanced Prostate Cancer Complicated With Severe Lower Urinary Tract Symptoms
- Lead sponsor
- The Third Xiangya Hospital of Central South University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 1, 2018
- Completion date
- November 30, 2025
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
advanced prostate cancer, lower urinary tract symptoms, overall survival, progression of prostate cancer, quality of life